Originally published October 28 2005
Generic drugs could save billions for consumers
by Mike Adams, the Health Ranger, NaturalNews Editor
Express Scripts Inc., a pharmacy benefit manager, has released a study that suggests consumers could have saved $20 billion last year by increasing their use of generic drugs over name brands.
- Consumers, their employers and commercial health plans could have saved more than $20 billion last year through increased use of generic drugs, according to a report being released Tuesday by Express Scripts Inc., a pharmacy benefit manager.
- It said that on average a generic drug costs about $60 less per month than a brand name medicine.
- Consumers also pay lower co-payments for generics, saving $10 or more per prescription.
- --------------------------------------------------------------------------------Pharmacy benefit managers administer drug plans and organize the purchase, dispensing and reimbursement of medicines for health insurers or other large purchasers of health care such as employers and unions.
- "We promote generics only when their use is clinically appropriate," Express Scripts said in a statement.
- "Our mission is to make the use of prescription drugs safer and more affordable.
- Generic drugs, because they are tried and true and less expensive, help us fulfill both the safety and affordability parts of this mission."
- As health care costs have continued to rise, health plans have been giving consumers inducements to use generic drugs through offering lower co-payments on such medicines.
- Dr. Steve Miller, Express Scripts Vice President of Research, said that many people still do not feel comfortable asking their doctor about generic alternatives to brand name drugs.
- Miller added that drug advertisements reinforce a brand's name and image to the consumer.
- He also noted that doctors have no incentive to write generic drug prescriptions, especially when they receive samples and other perks from pharmaceutical companies.
- The most dramatic savings potential is for generic gastrointestinal drugs, which treat problems like acid reflux disease, where costs could fall $5.4 billion nationally.
- Miller said patients only need newer, stronger branded products like AstraZeneca's PLC Nexium 5 percent of the time.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml